Tutorials
TSE:4570 (Japan)  
Immuno-Biological Laboratories Co Ltd logo

Immuno-Biological Laboratories Co Ltd

円 396.00 (-0.5%) Aug 12
P/E:
At Loss
P/B:
2.70
Market Cap:
円 3.69B ($ 27.69M)
Enterprise V:
円 3.41B ($ 25.63M)
Volume:
49.40K
Avg Vol (2M):
376.92K
Volume:
49.40K
Market Cap 円:
3.69B
Market Cap $:
27.69M
PE Ratio:
At Loss
Avg Vol (2-Month):
376.92K
Enterprise Value 円:
3.41B
Enterprise Value $:
25.63M
PB Ratio:
2.70
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Immuno-Biological Laboratories Co Ltd
1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005
Description
Immuno-Biological Laboratories Co., Ltd. focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.
Name Current Vs Industry Vs History
Cash-To-Debt 2.17
Equity-to-Asset 0.8
Debt-to-Equity 0.17
Debt-to-EBITDA -0.94
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.04
Distress
Grey
Safe
Beneish M-Score -3.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 37.65
9-Day RSI 46.77
14-Day RSI 50.7
6-1 Month Momentum % 9.45
12-1 Month Momentum % -27.77

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.95
Quick Ratio 3.52
Cash Ratio 2.23
Days Inventory 435.99
Days Sales Outstanding 94.6
Days Payable 8.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.2

Financials

TSE:4570's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 647.576
EPS (TTM) (円) -27.786
Beta 0.48
Volatility % 59.67
14-Day RSI 50.7
14-Day ATR (円) 24.743783
20-Day SMA (円) 400.6
12-1 Month Momentum % -27.77
52-Week Range (円) 285 - 530
Shares Outstanding (Mil) 9.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Immuno-Biological Laboratories Co Ltd Filings

Document Form Filing Date
No Filing Data